Frequencies for first 10,000 rows of drug6cl1 variable in nhamcsed2004 dataset : drug class #1 for medication #6 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, local (injectable) | 11 0.11 0.11 adjuncts to anesthesia/analeptics | 10 0.10 0.21 antimicrobial agents, unspecified | 1 0.01 0.22 penicillins | 10 0.10 0.32 cephalosporins | 16 0.16 0.48 erythromycins/lincosamides/macrolides | 10 0.10 0.58 tetracyclines | 5 0.05 0.63 aminoglycosides | 4 0.04 0.67 sulfonamides and trimethoprim | 2 0.02 0.69 urinary tract antiseptics | 1 0.01 0.70 miscellaneous antibacterial agents | 6 0.06 0.76 quinolones/derivatives | 11 0.11 0.87 antiviral agents | 3 0.03 0.90 deficiency anemias | 8 0.08 0.98 anticoagulants/thrombolytics | 16 0.16 1.14 hemostatics/antihemophelics | 1 0.01 1.15 cardiac glycosides | 5 0.05 1.20 antiarrhythmic agents | 2 0.02 1.22 antianginal agents | 13 0.13 1.35 vascular disorders, cerebral/peripheral | 1 0.01 1.36 agents used to treat shock/hypotension | 2 0.02 1.38 antihypertensive agents | 24 0.24 1.62 diuretics | 19 0.19 1.81 relaxants/stimulants, urinary tract | 2 0.02 1.83 calcium channel blockers | 22 0.22 2.05 beta blockers | 13 0.13 2.18 alpha agonist/alpha blockers | 6 0.06 2.24 ace inhibitors | 21 0.21 2.45 sedatives and hypnotics | 21 0.21 2.66 antianxiety agents | 18 0.18 2.84 antipsychotic/antimanics | 10 0.10 2.94 antidepressants | 16 0.16 3.10 anorexiants/cns stimulants | 1 0.01 3.11 alzheimer-type dementia | 1 0.01 3.12 antiemetics | 1 0.01 3.13 diagnostics, radiopaque & nonradioactiv | 1 0.01 3.14 disorders, acid/peptic | 35 0.35 3.49 antidiarrheals | 4 0.04 3.53 laxatives | 13 0.13 3.66 miscellaneous gastrointestinals | 3 0.03 3.69 antispasmodics/anticholinergics | 2 0.02 3.71 antacids | 4 0.04 3.75 metabolic and nurtient agents, unspec.. | 1 0.01 3.76 hyperlipidemia | 19 0.19 3.95 vitamins/minerals | 13 0.13 4.08 repl/regs of electrolytes/water balance | 25 0.25 4.33 calcium metabolism | 4 0.04 4.37 adrenal corticosteroids | 19 0.19 4.56 androgens/anabolic steroids | 1 0.01 4.57 estrogens/progestins | 2 0.02 4.59 blood glucose regulators | 24 0.24 4.83 thyroid/antithyroid | 3 0.03 4.86 relaxants/stimulants, uterine | 2 0.02 4.88 vaccines/antisera | 6 0.06 4.94 immunomodulators | 1 0.01 4.95 antiseptics/disinfectants | 2 0.02 4.97 dermatologics, misc. | 2 0.02 4.99 topical anti-infectives | 3 0.03 5.02 topical analgesics | 2 0.02 5.04 extrapyramidal movement disorders | 2 0.02 5.06 skeletal muscle hyperactivity | 7 0.07 5.13 anticonvulsants | 15 0.15 5.28 cycloplegics/mydriatics | 1 0.01 5.29 miscellaneous ophthalmics | 1 0.01 5.30 vertigo/motion sickness/vomiting | 5 0.05 5.35 analgesics/general | 3 0.03 5.38 analgesics, narcotic | 49 0.49 5.87 analgesics, non-narcotic | 45 0.45 6.32 antimigraine/other headaches | 1 0.01 6.33 antiarthritics | 4 0.04 6.37 antigout | 1 0.01 6.38 nsaid | 32 0.32 6.70 antiprotozoals | 4 0.04 6.74 antiasthmatics/bronchodilators | 28 0.28 7.02 nasal decongestants | 3 0.03 7.05 antitussives/expectorants/mucolytics | 8 0.08 7.13 antihistamines | 11 0.11 7.24 cold remedies | 1 0.01 7.25 corticosteroid-inhalation/nasal | 2 0.02 7.27 miscellaneous/unclassified | 2 0.02 7.29 unclassified | 10 0.10 7.39 . | 9,261 92.61 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016